Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc

Bullboard Posts

Comment by moderate_drumbowsion Jan 05, 2013 8:37pm

339 Views

Post# 20802346

RE: RE: RE: Shorting

It is fine to state opinions but the sentence "People that don't understand p values and stats bought this up to $4 - thanks." I interpreted as being obnoxious and I stand by that position. I did not buy in at 4, in fact I bought in consideably lower but just did not appreciate the tone to those that did. have a grand day

Bullboard Posts

Gold, growth and sustainability in focus for Mandalay Resources